Vijaya Diagnostic Centre (Mid Cap - High Growth) Share Target 2024, 2025 To 2039
|
Vijaya Diagnostic Centre Limited |
|||
|
Price: ₹1,042.30 | ||
| 52 Week Low: ₹596.05 52 Week High: ₹1,249.95 |
|||
| Market Capital: 7,950.62 Crore (Midcap) | |||
| Healthcare -> Diagnostics & Research | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Vijaya Diagnostic Centre Share Price Target For 2024
- 1.1.1: Vijaya Diagnostic Centre Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Vijaya Diagnostic Centre Share Price Target For 2025
- 1.2.1: Vijaya Diagnostic Centre Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Vijaya Diagnostic Centre Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Vijaya Diagnostic Centre Brief Company Overview
- 4: Vijaya Diagnostic Centre Financial Performance
- 4.0.1: Is Vijaya Diagnostic Centre A Good Buy For Long Term?
To predict the Vijaya Diagnostic Centre's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Vijaya Diagnostic Centre Share Price Target For 2024
The line chart displays the monthly closing prices of Vijaya Diagnostic Centre with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Vijaya Diagnostic Centre shares in 2024, see the table below.
Vijaya Diagnostic Centre Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 1093.25 (+4.88%) | Price Action: 11 Dec 2024 Low |
| 2024 Target 2 | 1079.36 (+3.55%) | Fibonacci Extension Level 23.60% |
| 2024 Target 1 | 1067.0 (+2.36%) | Price Action: 12 Dec 2024 Low |
| Current Price | 1042.30 | Vijaya Diagnostic Centre's share price as of 20 Dec 2024 |
| Stop Loss 1 | 1027.2 (-1.45%) | Fibonacci Retracement Level 98.60% |
| Stop Loss 2 | 1015.0 (-2.62%) | Price Action: 14 Nov 2024 Low |
| Stop Loss 3 | 991.25 (-4.90%) | Price Action: 05 Nov 2024 High |
Short-Term Technical Outlook
Current Technical Position: Vijaya Diagnostic Centre is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 50-day moving average at ₹1052.94 serves as the nearest technical reference point.
Historical Returns: 3-month: +8.65% | 6-month: +39.33% | 1-year: +54.43%
Vijaya Diagnostic Centre Share Price Target For 2025
The line chart displays the monthly closing prices of Vijaya Diagnostic Centre with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Vijaya Diagnostic Centre shares in 2025, see the table below.
Vijaya Diagnostic Centre Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 1510.58 (+44.92%) | Price Action: Chart |
| 2025 Target 2 | 1482.41 (+42.22%) | Price Action: Chart |
| 2025 Target 1 | 1467.73 (+40.81%) | Fibonacci Extension Level 64.90% |
| Current Price | 1042.30 | Vijaya Diagnostic Centre's share price as of 20 Dec 2024 |
| Stop Loss 1 | 945.0 (-9.34%) | Price Action: 29 Oct 2024 High |
| Stop Loss 2 | 925.54 (-11.21%) | Price Action: 30 Oct 2024 Low |
| Stop Loss 3 | 908.27 (-12.86%) | Technical Indicator: MA150 |
Long-Term Technical Outlook
52-Week Range Analysis: Vijaya Diagnostic Centre is currently trading at 68.2% of its 52-week range (₹596.05 - ₹1249.95).
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +54.43% | 3-year: +79.96% | 5-year: NA
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Vijaya Diagnostic Centre Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹1,042.30 | ||
| 2024 | ₹1,207.40 | +15.84% | ₹1,225.51 |
| 2025 | ₹1,884.93 | +56.11% | ₹1,913.20 |
| 2026 | ₹2,490.95 | +32.15% | ₹2,528.31 |
| 2027 | ₹3,209.97 | +28.87% | ₹3,258.12 |
| 2028 | ₹3,983.04 | +24.08% | ₹4,045.30 |
| 2029 | ₹4,627.17 | +16.17% | ₹4,696.58 |
| 2030 | ₹5,293.10 | +14.39% | ₹5,372.50 |
| 2031 | ₹5,798.71 | +9.55% | ₹5,885.69 |
| 2032 | ₹6,578.03 | +13.44% | ₹6,715.11 |
| 2033 | ₹7,437.35 | +13.06% | ₹7,605.05 |
| 2034 | ₹8,046.94 | +8.20% | ₹8,167.64 |
| 2035 | ₹8,701.26 | +8.13% | ₹8,831.78 |
| 2036 | ₹9,106.47 | +4.66% | ₹9,384.93 |
| 2037 | ₹9,946.09 | +9.22% | ₹10,095.28 |
| 2038 | ₹10,891.66 | +9.51% | ₹11,055.03 |
| 2039 | ₹11,066.22 | +1.60% | ₹11,438.36 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Vijaya Diagnostic Centre Brief Company Overview
Company Overview: Vijaya Diagnostic Centre Limited Vijaya Diagnostic Centre Limited, founded in 1981 and headquartered in Hyderabad, India, is a leading provider of diagnostic services in India. With a reputation for excellence in the industry, Vijaya offers a comprehensive...
range of services, including: Laboratory Services: Clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics Imaging Services: CT scan, MRI scan, ultrasound, digital X-ray Speciality Services: Cardiology, gastroenterology, nuclear medicine, PET/CT, multidetector computed tomography scan, MRI-3T Vijaya is committed to providing high-quality, accurate, and timely diagnostic services to patients. The company's commitment to excellence has earned it a strong reputation in the industry and among patients.Vijaya Diagnostic Centre Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 7,950.62 Crore | Market valuation of Vijaya Diagnostic Centre's shares. |
| Revenue (TTM) | 547.8 Crore | Total revenue generated by Vijaya Diagnostic Centre over the past twelve months. |
| Net Income (TTM) | +1,188,253,056.00 | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +30.16% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +21.69% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+28.29% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
+21.70% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
39.27 | Company's total debt divided by total shareholder equity. |
| Total Debt | 259.18 Crore | Sum of Vijaya Diagnostic Centre's current & long-term financial obligations. |
| Total Cash | 182.2 Crore | Total amount of liquid funds available to Vijaya Diagnostic Centre. |
| Beta | -0.05 | Beta is less than 1 indicating that the Vijaya Diagnostic Centre's price is less volatile than the market. |
Is Vijaya Diagnostic Centre A Good Buy For Long Term?
Vijaya Diagnostic Centre, with a revenue of ₹547.8 Crore and a net profit of ₹118.82 Crore in the last 12 months, can be considered a good buy for long-term investment. Its strong revenue growth of 28.29% compared to the previous quarter and a profit margin of 21.69% indicate its financial stability. The company's debt of ₹259.18 Crore and cash balance of ₹182.2 Crore should also be taken into account while making an investment decision.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
